Stock listing
Frankfurt:22Z Zealand Pharma A/S Aktie
German listing (Frankfurt) of Zealand Pharma A/S · home listing Copenhagen:ZEAL
Follow Zealand Pharma A/S into a list and get an email when it puts out news.
Share price · FWB:22Z
€30.64 EUR +0.66 (+2.2%)
Close on Oct 30, 2026
- Day range
- €30.64 – €30.64 EUROct 30, 2026
- Market cap
- €2.03B EURAt the close on Oct 30, 2026 · price × 66.33M shares outstanding
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| Copenhagen:ZEAL · Home | 231.50 DKK | -2.60 (-1.1%) | 228,918 | 231.90 | 233.70 | 229.80 | 234.10 | Close on Nov 2, 2026 |
| OTC:ZLDPF | $33.88 USD | -0.62 (-1.8%) | 117 | $33.88 | $33.88 | $33.88 | $34.50 | Close on Oct 23, 2026 |
| Frankfurt:22Z | €30.64 EUR | +0.66 (+2.2%) | — | €30.64 | €30.64 | €30.64 | €29.98 | Close on Oct 30, 2026 |
- Ticker
- Frankfurt:22Z
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Frankfurt
- Currency
- EUR
What changed lately
Latest news release · Oct 1, 2026
Zealand Pharma A/S announces Boehringer Ingelheim's survodutide achieves up to 13.1% weight loss in new Phase III trial, alongside significant improvements in glycemic control in people with obesity and type 2 diabetes
Latest deck · Aug 13, 2026
Q2 2026 Earnings Presentation
Earnings · 14 slides
Latest news
Decks
Q2 2026 Earnings Presentation
Earnings · 14 slides · Aug 13, 2026
Q1 2026 Earnings Presentation
Earnings · 17 slides · May 7, 2026
Barclays 28th Annual Global Healthcare Conference (March 2026)
Conference · 7 slides · Mar 11, 2026
Petrelintide Phase 2 ZUPREME-1 topline data conference call (March 2026)
Conference · 20 slides · Mar 5, 2026
Zealand Pharma A/S on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 65 in the last 12 months · 82 in all · newest Oct 1, 2026 · oldest 2025
- Decks
- 53 decks · latest Aug 13, 2026
Where Zealand Pharma A/S is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| Copenhagen:ZEAL · Home listing | Copenhagen | Denmark | DKK |
| LSIN:0NZU | LSIN | United Kingdom | DKK |
| gettex:22Z | gettex | Germany | EUR |
| Stuttgart:22Z | Stuttgart | Germany | EUR |
| OTC:ZLDPF | OTC | United States | USD |
| Tradegate:22Z | Tradegate | Germany | EUR |
| LS Exchange:A0YJW7 | LS Exchange | Germany | EUR |
| OTC:ZLDPY | OTC | United States | USD |
| Aquis:ZEALC | Aquis | United Kingdom | DKK |
| Lang & Schwarz:A0YJW7 | Lang & Schwarz | Germany | EUR |
| Frankfurt:22Z · This page | Frankfurt | Germany | EUR |
| Turquoise:ZEALC | Turquoise | United Kingdom | DKK |
| VIE:ZEAL | Vienna | Austria | EUR |
| BX Swiss:ZEAL | BX Swiss | Switzerland | CHF |
| Dusseldorf:22Z | Dusseldorf | Germany | EUR |
| Munich:22Z | Munich | Germany | EUR |
| Xetra:22Z | Xetra | Germany | EUR |
| Aquis:ZEALC | Aquis | United Kingdom | DKK |
| Frankfurt:22Z1 | Frankfurt | Germany | EUR |
| Hamburg:22Z | Hamburg | Germany | EUR |
| Hanover:22Z | Hanover | Germany | EUR |
Log in to ask 6ix AI your own questions about Zealand Pharma A/S.